↓ Skip to main content

Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology

Overview of attention for article published in European Journal of Heart Failure, March 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 2,570)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs
1 blog
twitter
635 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
Published in
European Journal of Heart Failure, March 2023
DOI 10.1002/ejhf.2814
Pubmed ID
Authors

Finn Gustafsson, Kevin Damman, Sanem Nalbantgil, Linda W. Van Laake, Laurens F. Tops, Thomas Thum, Stamatis Adamopoulos, Michael Bonios, Andrew JS Coats, Maria G. Crespo‐Leiro, Mandeep R. Mehra, Gerasimos Filippatos, Loreena Hill, Marco Metra, Ewa Jankowska, Nicolaas de Jonge, David Kaye, Marco Masetti, John Parissis, Davor Milicic, Petar Seferovic, Giuseppe Rosano, Tuvia Ben Gal

Abstract

This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart failure with evidence of organ malperfusion or shock. However, inotropic support may be reasonable in other patients with advanced heart failure without acute severe decompensation. The clinical evidence supporting use of inotropes in these situations is reviewed. Particularly, patients with persistent congestion, systemic hypoperfusion, or advanced heart failure with need for palliation, and specific situations relevant to implantation of left ventricular assist devices or heart transplantation are discussed. Traditional and novel drugs with inotropic effects are discussed and use of guideline directed therapy during inotropic support is reviewed. Finally, home inotropic therapy is described, and palliative care and end of life aspects are reviewed in relation to management of ongoing inotropic support (including guidance for maintenance and weaning of chronic inotropic therapy support). This article is protected by copyright. All rights reserved.

X Demographics

X Demographics

The data shown below were collected from the profiles of 635 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 13%
Unspecified 4 9%
Other 4 9%
Student > Doctoral Student 3 6%
Student > Postgraduate 3 6%
Other 7 15%
Unknown 20 43%
Readers by discipline Count As %
Medicine and Dentistry 19 40%
Unspecified 4 9%
Nursing and Health Professions 2 4%
Agricultural and Biological Sciences 1 2%
Mathematics 1 2%
Other 0 0%
Unknown 20 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 379. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#83,692
of 25,804,096 outputs
Outputs from European Journal of Heart Failure
#15
of 2,570 outputs
Outputs of similar age
#2,194
of 426,985 outputs
Outputs of similar age from European Journal of Heart Failure
#1
of 57 outputs
Altmetric has tracked 25,804,096 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,570 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,985 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.